Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.56
-0.13-1.69%
At close: -
$7.58
0.020.26%
After Hours: 7:37 PM EDT
Comments
Loading...
Novavax Analyst Ratings and Price Targets | NASDAQ:NVAX | Benzinga
Novavax Inc has a consensus price target of $48.13 based on the ratings of 8 analysts. The high is $168 issued by Cantor Fitzgerald on June 8, 2022. The low is $9 issued by JP Morgan on August 12, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on December 10, 2024, November 13, 2024, and November 12, 2024, respectively. With an average price target of $19 between HC Wainwright & Co., there's an implied 150.66% upside for Novavax Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
B. Riley Securities
JP Morgan
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Novavax
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 12/10/2024 | Buy Now | 150.66% | HC Wainwright & Co. | Vernon Bernardino52% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 150.66% | HC Wainwright & Co. | Vernon Bernardino52% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 150.66% | HC Wainwright & Co. | Vernon Bernardino52% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 10/16/2024 | Buy Now | 229.82% | Jefferies | Roger Song33% | $31 → $25 | Maintains | Buy | Get Alert |
| 10/10/2024 | Buy Now | 243.01% | B. Riley Securities | Mayank Mamtani71% | $23 → $26 | Reiterates | Buy → Buy | Get Alert |
| 10/02/2024 | Buy Now | 308.97% | Jefferies | Roger Song33% | $31 → $31 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | 203.43% | B. Riley Securities | Mayank Mamtani71% | $25 → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 18.73% | JP Morgan | Eric Joseph47% | $8 → $9 | Maintains | Underweight | Get Alert |
| 08/02/2024 | Buy Now | 229.82% | B. Riley Securities | Mayank Mamtani71% | $29 → $25 | Maintains | Buy | Get Alert |
| 07/30/2024 | Buy Now | 5.54% | JP Morgan | Eric Joseph47% | → $8 | Downgrade | Neutral → Underweight | Get Alert |
| 06/14/2024 | Buy Now | 137.47% | B of A Securities | Alec Stranahan33% | $12 → $18 | Maintains | Neutral | Get Alert |
| 05/23/2024 | Buy Now | 282.59% | B. Riley Securities | Mayank Mamtani71% | $11 → $29 | Maintains | Buy | Get Alert |
| 05/13/2024 | Buy Now | 150.66% | HC Wainwright & Co. | Vernon Bernardino52% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 31.93% | TD Cowen | Brendan Smith36% | $5 → $10 | Maintains | Hold | Get Alert |
| 05/10/2024 | Buy Now | 58.31% | B of A Securities | Alec Stranahan33% | $4 → $12 | Upgrade | Underperform → Neutral | Get Alert |
| 03/01/2024 | Buy Now | 150.66% | HC Wainwright & Co. | Vernon Bernardino52% | $35 → $19 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 45.12% | B. Riley Securities | Mayank Mamtani71% | $12 → $11 | Maintains | Buy | Get Alert |
| 11/10/2023 | Buy Now | 58.31% | B. Riley Securities | Mayank Mamtani71% | $15 → $12 | Maintains | Buy | Get Alert |
| 08/10/2023 | Buy Now | 361.74% | HC Wainwright & Co. | Vernon Bernardino52% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | Buy Now | 97.89% | B. Riley Securities | Mayank Mamtani71% | → $15 | Upgrade | Neutral → Buy | Get Alert |
| 05/10/2023 | Buy Now | 361.74% | HC Wainwright & Co. | Vernon Bernardino52% | $110 → $35 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | Buy Now | 31.93% | B. Riley Securities | Mayank Mamtani71% | $29 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 02/13/2023 | Buy Now | 1351.19% | HC Wainwright & Co. | Vernon Bernardino52% | → $110 | Reiterates | → Buy | Get Alert |
| 01/02/2023 | Buy Now | 1351.19% | HC Wainwright & Co. | Vernon Bernardino52% | $207 → $110 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | 994.99% | B. Riley Securities | Mayank Mamtani71% | $126 → $83 | Maintains | Buy | Get Alert |
| 09/22/2022 | Buy Now | 256.2% | JP Morgan | Eric Joseph47% | $132 → $27 | Downgrade | Neutral → Underweight | Get Alert |
| 08/09/2022 | Buy Now | 1351.19% | Cowen & Co. | Georgi Yordanov5% | $150 → $110 | Maintains | Outperform | Get Alert |
| 06/08/2022 | Buy Now | 2116.36% | Cantor Fitzgerald | Charles Duncan72% | $146 → $168 | Maintains | Overweight | Get Alert |
| 05/20/2022 | Buy Now | — | B of A Securities | Alec Stranahan33% | — | Initiates | → Underperform | Get Alert |
| 04/26/2022 | Buy Now | 2578.1% | B. Riley Securities | Mayank Mamtani71% | $250 → $203 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Novavax (NVAX) stock?
The latest price target for Novavax (NASDAQ:NVAX) was reported by HC Wainwright & Co. on December 10, 2024. The analyst firm set a price target for $19.00 expecting NVAX to rise to within 12 months (a possible 150.66% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Novavax (NVAX)?
The latest analyst rating for Novavax (NASDAQ:NVAX) was provided by HC Wainwright & Co., and Novavax reiterated their buy rating.
When was the last upgrade for Novavax (NVAX)?
The last upgrade for Novavax Inc happened on May 10, 2024 when B of A Securities raised their price target to $12. B of A Securities previously had an underperform for Novavax Inc.
When was the last downgrade for Novavax (NVAX)?
The last downgrade for Novavax Inc happened on July 30, 2024 when JP Morgan changed their price target from N/A to $8 for Novavax Inc.
When is the next analyst rating going to be posted or updated for Novavax (NVAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Novavax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Novavax was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.
Is the Analyst Rating Novavax (NVAX) correct?
While ratings are subjective and will change, the latest Novavax (NVAX) rating was a reiterated with a price target of $19.00 to $19.00. The current price Novavax (NVAX) is trading at is $7.58, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.